|
2.
|
PALINA: A phase II safety study of palbociclib in combination with letrozole or fulvestrant in African American women with hormone receptor positive HER2 negative advanced breast cancer. MedStar authors:
- Gallagher, Christopher
- Kamugisha, Lois
- Lynce, Filipa
- Mohebtash, Mahsa
- Saleh, Mervat
Year: 2018
Citation: - Contemporary Clinical Trials Communications. 10:190-192, 2018 Jun.
Institution:
- MedStar Good Samaritan Hospital
- MedStar Union Memorial Hospital
- Washington Cancer Institute
Medline publication type:
All authors: - Abu-Khalaf M, Cai L, Dilawari A, Gallagher C, Hahn O, Isaacs C, Kamugisha L, Lynce F, Mohebtash M, Pohlmann P, Saleh M, Shajahan-Haq A
|